CD19 and neoplasm: Constitutive expression of IL-2 by 1st generation CD19-CAR T cells improved the tumor-free survival of mice with disseminated lymphoma compared to CAR T cells alone, although other γc cytokines were associated with greater improvements in survival and longer persistence of CAR T cells (71).